首页|AFP、GP73及GPC3检测在原发性肝癌诊断及预后评估中的价值

AFP、GP73及GPC3检测在原发性肝癌诊断及预后评估中的价值

扫码查看
目的 分析血清甲胎蛋白(AFP)、高尔基体糖蛋白73(GP73)及磷脂酰肌醇蛋白聚糖3(GPC3)检测在原发性肝癌诊断及预后评估中的价值.方法 选取2021年5月至2022年5月郑州大学第一附属医院收治的原发性肝癌患者52例为研究对象,另外选取同期本院收治的肝硬化患者46例与健康体检者 48 名,分别设为肝硬化组与健康组.对比三组以及PHC组不同病理分期者AFP、GP73 及GPC3水平;比较PHC不同预后者的一般资料及AFP、GP73及GPC3水平,采用多元Logistic回归分析影响PHC预后的危险因素,绘制ROC曲线分析血清AFP、GP73及GPC3单独检测及联合检测诊断PHC的效果.结果 AFP、GP73、GPC3水平:PHC组>肝硬化组>健康组,差异具有统计学意义(P<0.05);PHC组不同病理分期者AFP、GP73、GPC3水平:Ⅳ期>Ⅲ期>Ⅱ期>Ⅰ期,差异具有统计学意义(P<0.05);预后良好组45例,预后不良组7例.两组性别、年龄、BMI指数比较,差异无统计学意义(P>0.05).两组凝血酶原、红细胞计数、载脂蛋白A1、GGT、AFP、GP73、GPC3水平比较,差异具有统计学意义(P<0.05);经多元Logistic回归分析显示,凝血酶原、红细胞计数、载脂蛋白A1、GGT、AFP、GP73、GPC3水平上升是影响PHC患者预后不良的危险因素(P<0.05);AFP、GP73、GPC3联合检测诊断PHC的敏感度、特异度分别为0.956、0.857;AUC=0.950(95%CI:0.909~0.991),明显高于AFP、GP73、GPC3 单独检测.结论 血清AFP、GP73、GPC3三者联合在PHC诊断中具有较高的临床价值,可用于PHC的早期诊断,临床可通过检测上述指标血清水平来评估PHC患者的预后情况.
Value of serum AFP,GP73 and GPC3 detection in the diagnosis and prognosis assessment of primary liver cancer
Objective To evaluate the value of serum alpha-fetoprotein(AFP),Golgi glycopro-tein 73(GP73)and phosphatidyl inositol proteoglycan 3(GPC3)detection in the diagnosis and prognosis of primary liver cancer.Methods 52 patients with primary liver cancer admitted to the First Affiliated Hospital of Zhengzhou University from May 2021 to May 2022 were selected as the study objects,another 46 cases with cirrhosis and 48 cases healthy physical examination admitted to our hospital during the same period were selected as the cirrhosis group and the health group,respectively.The levels of AFP,GP73 and GPC3 were compared among the three groups and the PHC group at different pathological stages;the general prognostic data of PHC and levels of AFP,GP73 and GPC3 were compared;Multiple logistic regression was used to ana-lyze the risk factors affecting the prognosis of PHC.The ROC curve was drawn to analyze the diagnostic effect of serum AFP,GP73 and GPC3 alone and combined detection of PHC.Results The levels of AFP,GP73 and GPC3 were as follows:PHC group>cirrhosis group>healthy group,the difference was statistically sig-nificant(P<0.05).AFP,GP73,GPC3 levels in the PHC group with different pathological stages were:Ⅳ>Ⅲ>Ⅱ>Ⅰ,the difference was statistically significant(P<0.05).There were 45 cases in the good prognosis group and 7 cases in the poor prognosis group.There was no significant difference in gender,age and BMI be-tween the two groups(P>0.05).The levels of prothrombin,red blood cell count,apolipoprotein A1,GGT,AFP,GP73 and GPC3 were significantly different between the two groups(P<0.05).Multiple logistic regres-sion analysis showed that the increased levels of prothrombin,red blood cell count,apolipoprotein A1,GGT,AFP,GP73 and GPC3 were risk factors for poor prognosis in PHC patients(P<0.05).The sensitivity and specificity of the combination of AFP,GP73 and GPC3 for diagnosis and prognosis of PHC were 0.956 and 0.857,respectively;The AUC=0.950(95%CI:0.909~0.991),which was significantly higher than AFP,GP73,GPC3 detection alone.Conclusion The combination of serum AFP,GP73 and GPC3 has a high clini-cal value in the diagnosis of PHC and can be used for the early diagnosis of PHC.The prognosis of patients with PHC can be evaluated by detecting the serum levels of the above indicators.

AFPGP73GPC3Primary liver cancer

何平、徐婧怡、张雪雪、陈晓龙

展开 >

郑州大学第一附属医院感染科,河南,郑州 450000

郑州大学第一附属医院耳科,河南,郑州 450000

AFP GP73 GPC3 原发性肝癌

河南省科技攻关计划

232102311030

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(1)
  • 13